BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 18232160)

  • 1. Review of screening and preventive strategies for cervical cancer in India.
    Patro BK; Nongkynrih B
    Indian J Public Health; 2007; 51(4):216-21. PubMed ID: 18232160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.
    Akinola OI; Fabamwo AO; Oshodi YA; Banjo AA; Odusanya O; Gbadegesin A; Tayo A
    J Obstet Gynaecol; 2007 Oct; 27(7):703-5. PubMed ID: 17999297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
    Tayyeb R; Khawaja NP; Malik N
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for cancer of uterine cervix and approaches adopted in India.
    Murthy NS; Mathew A
    Indian J Cancer; 1999; 36(2-4):154-62. PubMed ID: 10921220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer in developing countries: effective screening and preventive strategies with an application in Rwanda.
    Mukakalisa I; Bindler R; Allen C; Dotson J
    Health Care Women Int; 2014; 35(7-9):1065-80. PubMed ID: 24750113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
    Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
    Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downstaging of cervical cancer.
    Ananth R
    J Indian Med Assoc; 2000 Feb; 98(2):41-4. PubMed ID: 11016148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer control in developing countries: memorandum from a WHO meeting.
    Bull World Health Organ; 1996; 74(4):345-51. PubMed ID: 8823955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of cervical cancer screening for prevention of carcinoma cervix.
    Christe DM; Mohanambal M; Ramamurthy V; Snehaa NB
    J Indian Med Assoc; 2008 Dec; 106(12):779-80, 782. PubMed ID: 19370947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
    Sepúlveda C; Prado R
    Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and prevention: cervical cancer.
    Weinstein LC; Buchanan EM; Hillson C; Chambers CV
    Prim Care; 2009 Sep; 36(3):559-74. PubMed ID: 19616155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer in India--strategy for control.
    Prabhakar AK
    Indian J Cancer; 1992 Sep; 29(3):104-13. PubMed ID: 1292993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
    Misra JS; Gupta HP; Das V
    Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.